drugset / Trial / NCT02642523

Natriuretic Peptides and Metabolic Risk in Obesity

NCT02642523

Non-randomizedCrossoverOpen-labelOther

Summary

The investigators are examining: 1. the relationships of insulin levels and natriuretic peptide hormone levels, and 2. the effects of administering an infusion of natriuretic peptide hormone on the breakdown of fat in healthy lean and otherwise healthy obese individuals.

Timeline

Start
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Intravenous
Subject Nesiritide Protein / enzyme biologic 0.01 ug/kg Intravenous